Newly Diagnosed Multiple Myeloma Recruiting Phase 2 Trials for Ixazomib (DB09570)

Also known as: Newly Diagnosed Multiple Myeloma (NDMM) / Newly Diagnosed, Multiple Myeloma / Multiple Myeloma, Newly Diagnosed

IndicationStatusPhase
DBCOND0036257 (Newly Diagnosed Multiple Myeloma)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04052880Study of SubQ Dara With Dose-Attenuated Bortezomib, Lenalidomide, Dexamethasone in Elderly NDMMTreatment